ZNF217 and breast carcinoma: Again, both ZNF217-WT (E3-E4) and ZNF217-ΔE4 (E3-E5) isoforms display significant mRNA expression differences between the breast cancer molecular subtypes (p = 0.007 and p = 0.056, respectively, Kruskal-Wallis Test, data not shown).